Insulin resistance in nondiabetic morbidly obese patients: Effect of bariatric surgery

Obesity Research

Volumn 11, Issue 12, 2003, Pages 1495-1501

  Pereira, Juliano Alves ^a   Lazarin, Mary Aparecida C T ^a   Pareja, José Carlos ^a   De Souza, Aglécio ^a   Muscelli, Elza ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

Bariatric surgery; Glucose metabolism; Insulin clamp; Insulin resistance; Insulinemia

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLOOD; CALORIMETRY; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MORBID OBESITY; PHYSIOLOGY; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; ENERGY METABOLISM; FEMALE; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY, MORBID; WEIGHT LOSS;

EID: 2142745876     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.200     Document Type: Article

References (34)

1. World Health Organization. Obesity Preventing and Managing the Global Epidemic. Geneva, Switzerland: World Health Organization; 1998.
2. Donahue RP, Abbot RD, Bloom E, et al. Central obesity and coronary heart disease. Lancet. 1987;1:821-4.
3. Bloomgarden Z. Obesity and Diabetes. Diabetes Care. 2000;23:1584-90.
4. Sjöström L. Mortality of severely obese subjects. Am J Clin Nutr. 1992;55:516-23S.
5. Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID. The prevalence of obstructive sleep apnea in an obese female population. Int J Obes Relat Metab Disord. 1994;18:173-7.
6. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997;21:S5-9.
7. Bray GA. Overweight is risking fate: definition, classification, prevalence, and risks. Ann N Y Acad Sci. 1987;499:14-28.
8. Ferrannini E. Insulin resistance and hyperinsulinemia: why are they important? Curr Opin Endocrinol Diabetes. 1999;6:S13-6.
9. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
10. Muscelli E, Camastra S, Catalano C, et al. Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. J Clin Endocrinol Metab. 1997;82:2937-43.
11. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab. 2000;278/3:E501-8.
12. Pories WJ, Macdonald KG Jr., Flickinger EG, et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg. 1992;215:633-42.
13. Sjöstrom CD, Lissner L, Sjöstrom L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Swedish Obese Subjects. Obes Res. 1997;5:519-30.
14. Mingrone G, De Gaetano A, Greco AV, et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia. 1997;40:599-605.
15. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab. 1995;80:364-9.
16. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002;51:144-51.
17. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab. 1987;64:661-8.
18. Burstein R, Epstein Y, Charuzi I, Suessholz A, Karnieli E, Shapiro Y. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes Relat Metab Disord. 1995;19:558-61.
19. Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg. 1999;9:516-23.
20. Capella JF, Capella RF. The weight reduction operation of choice: Vertical banded gastroplasty or gastric bypass? Am J Surg. 1996;171:74-9.
21. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-83.
22. American Diabetes Association. Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
23. Fobi MAL, Lee H, Igwe D, et al. Revision of failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases. Obes Surg. 2001;11:190-5.
24. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23.
25. McGuire EAH, Heldermann JH, Tobin JD, Andres R, Berman M. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol. 1976;41:1312-8.
26. Ferrannini E, Cobelli C. The kinetics of insulin in man: general aspects. Diab Metab Rev. 1987;3:335-63.
27. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 1988;37/3:287-301.
28. MacDonald PE, El-kholy W, Riedel MJ et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes. 2002;51:S434-42.
29. Naslund E, Backman L, Holst JJ, Theodorsson E, et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8:253-60.
30. Sirinek KR, D'orisio TM, Hill D, et al. Hyperinsulinism, glucose dependent insulinotropic polypeptide and the entero-insular axis in morbidly obese patients before and after gastric bypass. Surgery. 1986;100:781-7.
31. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab. 1986;62/5:922-7.
32. Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. Am J Clin Nutr. 1992;55:356-61.
33. Tappy L, Felber JP, Jéquier E. Energy and substrate metabolism in obesity and postobese state. Diabetes Care. 1991;14:1180-8.
34. Hale PJ, Singh BM, Crase J, Baddeley RM, Nattrass M. Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism. Metabolism. 1988;37/5:411-7.